ASSESSING PREGNANCY RISKS OF AZOLE ANTIFUNGALS USING A HIGH THROUGHPUT AROMATASE INHIBITION ASSAY

REFERENCES

• Kragie L. Aromatase in Primate Pregnancy: A Review. Endocrine Research 2002; 28(3)121–128
   PubMed Web of Science ®Google Scholar
• Osawa Y., Higashiyama T., Toma Y., Yarborough C. Diverse Function of Aromatase and the N-Terminal Sequence Deleted Form. J. Steroid Biochem. Mol. Biol. 1997; 61(3–6)117–126
   PubMed Web of Science ®Google Scholar
• Simpson E. R., Mahendroo M. S., Means G. D., Kilgore M. W., Hinshelwood M. M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C. R., Michael M. D. Aromatase Cytochrome P450, the Enzyme Responsible for Estrogen Biosynthesis. Endocr. Rev. 1994; 15(3)342–355, et al.
   PubMed Web of Science ®Google Scholar
• Labrie F. DHEA as Physiological Replacement Therapy at Menopause. J. Endocrinol. Invest. 1998; 21(6)399–401
   PubMed Web of Science ®Google Scholar
• Adams J. B. Control of Secretion and the Function of C19-Delta 5-Steroids of the Human Adrenal Gland. Mol. Cell. Endocrinol. 1985; 41(1)1–17
   PubMed Web of Science ®Google Scholar
• Resko J. A., Roselli C. E. Prenatal Hormones Organize Sex Differences of the Neuroendocrine Reproductive System: Observations on Guinea Pigs and Nonhuman Primates. Cell Mol. Neurobiol. 1997; 17(6)627–648
   PubMed Web of Science ®Google Scholar
• Kao Y. C., Higashiyama T., Sun X., Okubo T., Yarborough C., Choi I., Osawa Y., Simmen F. A., Chen S. Catalytic Differences Between Porcine Blastocyst and Placental Aromatase Isozymes. Eur. J. Biochem. 2000; 267(20)6134–6139
   PubMedGoogle Scholar
• Albrecht E. D., Aberdeen G. W., Pepe G. J. The Role of Estrogen in the Maintenance of Primate Pregnancy. Am. J. Obstet. Gynecol. 2000; 182(2)432–438
   PubMed Web of Science ®Google Scholar
• Nathanielsz P. W., Jenkins S. L., Tame J. D., Winter J. A., Guller S., Giussani D. A. Local Paracrine Effects of Estradiol are Central to Parturition in the Rhesus Monkey. Nat. Med. 1998; 4(4)456–459
   PubMed Web of Science ®Google Scholar
• Mason J. I., Murry B. A., Olcott M., Sheets J. J. Imidazole Antimycotics: Inhibitors of Steroid Aromatase. Biochemical Pharmacology 1985; 34: 1087–1092
   PubMed Web of Science ®Google Scholar
• Ayub M., Levell M. J. Structure-Activity Relationships of the Inhibition of Human Placental Aromatase by Imidazole Drugs Including Ketoconazole. J. Steroid Biochem. 1988; 31(1)65–72
   PubMedGoogle Scholar
• Kragie L., Amri H., Gore L., Flockhart D., Papadopoulos V. (1996) 1996 Cytochrome P450 Aromatase: An In Vitro Screening Tool for Drug-Steroid Interactions. 10th International Congress of Endocrinology. June, 1996. Endocrine Society, San Francisco, CA, Program Abstract #P3-480 p. 874.
   Google Scholar
• Stresser D. M., Turner S. D., McNamara J., Stocker P., Miller V. P., Crespi C. L., Patten C. J. A High-Throughput Screen to Identify Inhibitors of Aromatase (CYP19). Anal. Biochem. 2000; 284(2)427–430
   PubMed Web of Science ®Google Scholar
• Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Maenpaa J., Edwards R. J., Boobis A. R., Raunio H. Expression of Xenobiotic-Metabolizing Cytochrome P450 Forms in Human Full-Term Placenta. Biochem. Pharmacol. 1996; 51(4)403–411
   PubMed Web of Science ®Google Scholar
• Fromtling R. A. Overview of Medically Important Antifungal Azole Derivatives. Clin. Microbiol. Rev. 1988; 1(2)187–217
   PubMedGoogle Scholar
• Spectazole® Package Insert. Physicians Desk Reference. Medical Economics Company Inc., Montvale, NJ 2000
   Google Scholar
• Plempel M. Pharmacokinetics of Imidazole Antimycotics. Postgrad. Med. J. 1979; 55(647)662–666
   PubMedGoogle Scholar
• Midgley I., van Bladeren P. J., Hawkins D. R., Chasseaud L. F., Darragh A., Brodie R. R., Walmsley L. M. The Metabolic Fate of [3H]Econazole in Man. Xenobiotica 1981; 11(9)595–608
   PubMed Web of Science ®Google Scholar
• Patzschke K., Ritter W., Siefert H. M., Weber H., Wegner L. A. Pharmacokinetic Studies Following Systemic and Topical Administration of [14C]Bifonazole in Man. Arzneimittelforschung 1983; 33(5)745–750
   PubMed Web of Science ®Google Scholar
• Lackner T. E., Clissold S. P. Bifonazole. A Review of its Antimicrobial Activity and Therapeutic Use in Superficial Mycoses. Drugs 1989; 38(2)204–225
   PubMed Web of Science ®Google Scholar
• Lucker P. W., Beubler E., Kukovetz W. R., Ritter W. Retention Time and Concentration in Human Skin of Bifonazole and Clotrimazole. Dermatologica 1984; 169(1)51–55
   PubMedGoogle Scholar
• Myclex-G® Package Insert. Physicians Desk Reference. Medical Economics Company Inc., Montvale, NJ 2000
   Google Scholar
• Heel R. C., Brogden R. N., Pakes G. E., Speight T. M., Avery G. S. Miconazole: A Preliminary Review of Its Therapeutic Efficacy in Systemic Fungal Infections. Drugs 1980; 19(1)7–30
   PubMed Web of Science ®Google Scholar
• Daneshmend T. K. Systemic Absorption of Miconazole from the Vagina. J. Antimicrob. Chemother. 1986; 18(4)507–511
   PubMed Web of Science ®Google Scholar
• Beggs W. H. Fungistatic Activity of Miconazole Against Candida Albicans in Relation to pH and Concentration of Nonprotonated Drug. Mycoses 1989; 32(5)239–244
   PubMed Web of Science ®Google Scholar
• Franz T. J., Lehman P. Percutaneous Absorption of Sulconazole Nitrate in Humans. J. Pharm. Sci. 1988; 77(6)489–491
   PubMed Web of Science ®Google Scholar
• Nizoral® Package Insert. Physicians Desk Reference. Medical Economics Company Inc., Montvale, NJ 2000
   Google Scholar
• Mikamo H., Kawazoe K., Sato Y., Izumi K., Ito T., Ito K., Tamaya T. Penetration of Oral Fluconazole Into Gynecological Tissues. Antimicrob. Agents Chemother. 1999; 43(1)148–151
   PubMed Web of Science ®Google Scholar
• Schramm P., Wildfeuer A., Sarnow E. Determination of Fluconazole Concentrations in the Prostatic and Seminal Vesicle Fluid (Split Ejaculate). Mycoses 1994; 37(11–12)417–420
   PubMed Web of Science ®Google Scholar
• Garcia-Hermoso D., Dromer F., Improvisi L., Provost F., Dupont B. Fluconazole Concentrations in Saliva from AIDS Patients with Oropharyngeal Candidosis Refractory to Treatment with Fluconazole. Antimicrob. Agents Chemother. 1995; 39(3)656–660
   PubMed Web of Science ®Google Scholar
• Rieder-Nelissen C. M., Hasse J., Yeates R. A., Sarnow E. Fluconazole Concentrations in Pulmonary Tissue and Pericardial Fluid. Infection 1997; 25(3)192–194
   PubMed Web of Science ®Google Scholar
• Wenzl T. G., Schefels J., Hornchen H., Skopnik H. Pharmacokinetics of Oral Fluconazole in Premature Infants. Eur. J. Pediatr. 1998; 157(8)661–662
   PubMed Web of Science ®Google Scholar
• Monistat® Package Insert. Physicians Desk Reference. Medical Economics Company Inc., Montvale, NJ 1991
   Google Scholar
• Sasaki J., Yamamoto T., Okada H. The Synergistic Abortive Effect of Anti-Progestogen RU 38486 and Aromatase Inhibitors for Pregnant Rat. Nippon Sanka Fujinka Gakkai Zasshi 1989; 41(2)179–184
   PubMedGoogle Scholar
• Beltrame D., di Salle E., Giavini E., Gunnarsson K., Brughera M. Reproductive Toxicity of Exemestane, an Antitumoral Aromatase Inactivator, in Rats and Rabbits. Reprod. Toxicol. 2001; 15(2)195–213
   PubMed Web of Science ®Google Scholar
• Pursley T. J., Blomquist I. K., Abraham J., Andersen H. F., Bartley J. A. Fluconazole-Induced Congenital Anomalies in Three Infants. Clin. Infect. Dis. 1996; 22(2)336–340
   PubMed Web of Science ®Google Scholar
• Lee B. E., Feinberg M., Abraham J. J., Murthy A. R. Congenital Malformations in an Infant Born to a Woman Treated with Fluconazole. Pediatr. Infect. Dis. J. 1992; 11(12)1062–1064
   PubMed Web of Science ®Google Scholar
• King C. T., Rogers P. D., Cleary J. D., Chapman S. W. Antifungal Therapy During Pregnancy. Clin. Infect. Dis. 1998; 27(5)1151–1160
   PubMed Web of Science ®Google Scholar
• Sorensen H. T., Nielsen G. L., Olesen C., Larsen H., Steffensen F. H., Schonheyder H. C., Olsen J., Czeizel A. E. Risk of Malformations and Other Outcomes in Children Exposed to Fluconazole in Utero. Br. J. Clin. Pharmacol. 1999; 48(2)234–238
   PubMed Web of Science ®Google Scholar
• Rosa F. W., Baum C., Shaw M. Pregnancy Outcomes After First-Trimester Vaginitis Drug Therapy. Obstet. Gynecol. 1987; 69(5)751–755
   PubMed Web of Science ®Google Scholar
• Drugs for Vulvovaginal Candidiasis. Med. Lett. Drugs Ther. 2001; 43(1095)3–4
   PubMed Web of Science ®Google Scholar
• Czeizel A. E., Rockenbauer M. A Lower Rate of Preterm Birth After Clotrimazole Therapy During Pregnancy. Paediatr. Perinat. Epidemiol. 1999; 13(1)58–64
   PubMed Web of Science ®Google Scholar